PLSE insider transaction filings
PULSE BIOSCIENCES, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-02. Screen PLSE transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 4 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings by 1 insider — 4,095 shares, $199,937 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 1,001 shares @ $49.95 ($50,000) by Teplitsky Liane Rae, filed 2026-09-02.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Teplitsky Liane Rae — Chief Operating Officer | 3 | 4 legs · 4,095 sh · $199,937 | — | 2 |
| Skinner Jon — Chief Financial Officer | 1 | — | — | 1 |
Recent Form 4 filings — PULSE BIOSCIENCES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Teplitsky Liane Rae — Chief Operating Officer | Purchase (P): 1,024 @ $48.80 · Purchase (P): 1,001 @ $49.95 | EDGAR |
| 2026-08-28 | 4 | Teplitsky Liane Rae — Chief Operating Officer | Purchase (P): 1,036 @ $48.23 · Purchase (P): 1,034 @ $48.35 | EDGAR |
| 2026-08-28 | 4 | Teplitsky Liane Rae — Chief Operating Officer | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | Skinner Jon — Chief Financial Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Soni Manmeet Singh — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Zanganeh Mahkam — Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 14,504 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Sainz Maria — Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 3,793 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | van den Broek Richard — Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 8,423 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | DUGGAN ROBERT W — Director, 10% owner | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 12,495 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4/A | DUGGAN ROBERT W — Director, 10% owner | Purchase (P): 660,233 @ $19.69 | EDGAR |
| 2026-05-11 | 4 | LAVIOLETTE PAUL A — Chief Executive Officer, Director | Purchase (P): 15,000 @ $19.69 | EDGAR |
| 2026-05-11 | 4/A | LAVIOLETTE PAUL A — Chief Executive Officer, Director | Purchase (P): 15,000 @ $19.69 | EDGAR |
| 2026-05-11 | 4 | DUGGAN ROBERT W — Director, 10% owner | Purchase (P): 660,233 @ $19.69 | EDGAR |
| 2026-04-03 | 4 | UECKER DARRIN — Chief Technology Officer, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise (M): 5,000 @ $1.53 · Sale (S): 5,000 @ $23.64 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.37 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.53 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.63 · +3 more | EDGAR |
| 2026-02-11 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $21.45 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.52 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $25.20 · +3 more | EDGAR |
| 2026-02-06 | 4 | Sainz Maria — Director | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 3,104 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise (M): 4,600 @ $1.53 · Sale (S): 4,600 @ $18.53 · Option exercise (M): 4,600 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $18.49 · Option exercise (M): 400 @ $1.53 · Sale (S): 400 @ $18.48 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4 | UECKER DARRIN — Chief Technology Officer, Director | Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $16.28 · Option exercise (M): 20,000 @ $4 · Sale (S): 20,000 @ $16.21 · Option exercise (M): 61,534 @ $4 · Option exercise (M): 100,000 @ $4 · +4 more | EDGAR |
| 2025-09-15 | 4 | UECKER DARRIN — Chief Technology Officer, Director | Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $14.78 · Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $14.32 · Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $15.77 · +3 more | EDGAR |
| 2025-09-12 | 4 | DUGGAN ROBERT W — Director, 10% owner | Purchase (P): 34,659 @ $14.66 · Purchase (P): 12,800 @ $14.77 · Purchase (P): 145,140 @ $14.41 | EDGAR |
| 2025-08-19 | 4 | Soni Manmeet Singh — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Zanganeh Mahkam — Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 24,134 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | van den Broek Richard — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | DUGGAN ROBERT W — Director, 10% owner | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 20,792 (derivative) @ $0 | EDGAR |
| 2025-07-16 | 4 | Weber Steven — Principal Accounting Officer | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | UECKER DARRIN — Chief Technology Officer, Director | Sale (S): 15,000 @ $16.40 · Sale (S): 15,000 @ $15.98 | EDGAR |
| 2025-02-11 | 4 | Zanganeh Mahkam — Director | Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 (derivative) @ $0 · Option exercise/expiry (X): 30,121 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | LAVIOLETTE PAUL A — Chief Executive Officer, Director | Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 1,050,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Barrett Burke Thomas | Sale (S): 50,000 @ $17.42 | EDGAR |
| 2024-12-18 | 4 | DUGGAN ROBERT W — Director, 10% owner | Option exercise/expiry (X): 5,187,824 @ $11 · Option exercise/expiry (X): 69,020 @ $11 · Option exercise/expiry (X): 49,312 @ $11 · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 34,510 (derivative) · +3 more | EDGAR |
| 2024-12-17 | 4 | DUGGAN ROBERT W — Director, 10% owner | Purchase (P): 55,256 @ $17.18 | EDGAR |
| 2024-12-13 | 4 | DUGGAN ROBERT W — Director, 10% owner | Purchase (P): 6,054 @ $16.74 · Purchase (P): 50,000 @ $17.42 | EDGAR |
| 2024-09-30 | 4 | Levinson Mitchell E. — Chief Strategy Officer | Option exercise/expiry (X): 3,000 @ $11 · Option exercise/expiry (X): 1,240 @ $11 · Option exercise/expiry (X): 322 @ $11 · Option exercise/expiry (X): 322 @ $11 · Option exercise/expiry (X): 322 @ $11 · Option exercise/expiry (X): 1,500 (derivative) · +9 more | EDGAR |
| 2024-08-13 | 4 | Soni Manmeet Singh — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Zanganeh Mahkam — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | LAVIOLETTE PAUL A — Director | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | Barrett Burke Thomas — President and CEO, Director | Option exercise/expiry (X): 543 @ $11 · Option exercise/expiry (X): 543 @ $11 · Option exercise/expiry (X): 543 (derivative) @ $0 · Option exercise/expiry (X): 543 (derivative) @ $0 | EDGAR |
| 2024-07-09 | 4 | Danahy Kevin Patrick — Chief Commercial Officer | Option exercise/expiry (X): 650 · Purchase (P): 325 (derivative) · Purchase (P): 325 (derivative) | EDGAR |
| 2024-07-09 | 4 | Zanganeh Mahkam — Director | Option exercise/expiry (X): 60,242 · Purchase (P): 30,121 (derivative) · Purchase (P): 30,121 (derivative) | EDGAR |
| 2024-07-09 | 4 | DUGGAN ROBERT W — Director, 10% owner | Option exercise/expiry (X): 5,187,824 · Option exercise/expiry (X): 69,020 · Option exercise/expiry (X): 49,312 · Purchase (P): 2,593,912 (derivative) · Purchase (P): 2,593,912 (derivative) · Purchase (P): 34,510 (derivative) · +3 more | EDGAR |
| 2024-07-08 | 4 | Levinson Mitchell E. — Chief Strategy Officer | Option exercise/expiry (X): 3,000 · Option exercise/expiry (X): 1,241 · Option exercise/expiry (X): 322 · Option exercise/expiry (X): 322 · Option exercise/expiry (X): 322 · Purchase (P): 1,500 (derivative) · +9 more | EDGAR |
| 2024-07-08 | 4 | Barrett Burke Thomas — President and CEO, Director | Option exercise/expiry (X): 1,086 · Purchase (P): 543 (derivative) · Purchase (P): 543 (derivative) | EDGAR |
| 2024-06-24 | 4 | Barrett Burke Thomas — President and CEO, Director | Grant/award (A): 700,000 (derivative) @ $0 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Soni Manmeet Singh — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Zanganeh Mahkam — Director | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 8,247 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | van den Broek Richard — Director | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 11,649 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | DUGGAN ROBERT W — Director, 10% owner | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 16,247 (derivative) @ $0 | EDGAR |
Recent 8-K events — PULSE BIOSCIENCES, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PLSE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →